Increasing access to medical training with 3D printing: the endotracheal intubation model
Related Articles
-
The Clinician Advocate: How Evidence and Anecdote Produce Change
Phoebe Adams, , 2017, The Talks DASsmacc, Advocate, Alcohol, clinician, Emergency Departments, public health, 0
Emergency departments are at the forefront of dealing with the harmful effects of alcohol consumption. ED alcohol-related presentation data...
-
-
Helping Without Harming
Phoebe Adams, , 2017, The Talks DASsmacc, communication in critical care, Debriefing, feedback, interprofessional education, negotiation, performance gaps, 0
You’ve been resuscitating the patient for hours and finally caught up with volume. You come back on your next...
-
NeuroImaging Nibble Subtle Sinus Venous Thrombosis
Phoebe Adams, , 2017, The Talks DASsmacc, NeuroImaging, Subtle Sinus Venous Thrombosis, 0
Neuro Imaging Nibble: Subtle Sinus Venous Thrombosis by Brandon Foreman
-
SMACCMini: Living dangerously – CPR for the Fontan patient
Phoebe Adams, , 2017, children, CPR, fontan, 0
SMACCMini: Living dangerously – CPR for the Fontan patient by Timo de Raad
-
Diagnosing a wake-up stroke (look to the future) – imaging, implications on treatment
Phoebe Adams, , 2017, The Talks DASsmacc, DasSMACC, wake up stroke, 0
Diagnosing a wake-up stroke by Fernanda Bellolio
-
Diagnosing critical neuromuscular disease – physical exam findings, ancillary tests
Phoebe Adams, , 2017, The Talks DASsmacc, Neurology; Resuscitation; Emergency Medicine; Neuromuscular; Respiratory Failure; Physical Exam; Neurocritical Care, 0
Neuromuscular diseases are common and include chronic autoimmune disorders such as myasthenia gravis, acute demyelinating disorders like Guillain Barre,...
-
Righting the Wrongs of Research
Phoebe Adams, , 2017, The Talks DASsmacc, Bayesian adaptive trials, big data, critical care, critical care research, ICU research, randomised controlled trials, research methods, response adaptive randomization, 0
Mortality measured at a particular time point (landmark mortality) is often regarded as the gold standard outcome for randomised...
0 Comments